TransMedics TMDX Cash Flow Statement (2018-2026)

NASDAQ TMDX
$86.40 -1.87 (-2.12%)
As of: Sep 9, 2026 · 3:59 PM EDT
Reported Financials

TransMedics Quarterly Cash Flow Statement

Periods 34 quarters
Latest Jun 2026

TransMedics reported cash from operations of $17.31M and free cash flow of $10.22M for the quarter ended Jun 2026, down 81.1% year over year. This cash flow statement covers 34 quarters of results from Mar 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-12.96M-12.81M-10.56M-11.52M-7.43M-6.97M-2.64M-1.00M-25.42M3.66M12.20M12.19M4.22M6.87M25.68M34.88M24.33M124.93M7.29M14.68M
Share-based CompensationStock Comp.
1.97M1.99M2.31M2.32M2.70M2.99M3.92M4.96M5.19M5.72M6.87M7.64M7.94M10.77M8.96M9.37M67.50M9.39M59.10M54.40M
Deferred Taxes
-0.12M1.07M3.80M
Gains from Investment SecuritiesGains Investment
Cash from OperationsCash from Ops.
-9.35M-6.65M-18.41M-9.09M-14.28M-4.04M-8.66M-5.80M-6.87M8.30M-3.44M25.72M6.86M19.66M-2.85M91.61M69.57M34.51M24.53M17.31M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
0.31M0.28M0.23M0.14M0.01M
Depreciation & Amortization (CF)Dep. & Amort.
0.46M0.47M0.51M0.80M0.89M1.28M1.30M1.40M1.90M3.60M4.30M4.50M5.10M5.68M6.14M6.70M6.80M7.47M11.86M10.30M
Change in Working Capital
Change in ReceivablesChange Receivables
-2.09M1.81M5.80M1.33M9.16M5.39M10.96M8.90M11.13M2.82M18.41M-0.76M8.82M7.84M44.13M-37.52M-24.15M3.58M6.52M13.43M
Change in InventoryChange Inventory
2.07M0.93M2.93M1.23M1.94M1.93M3.62M7.35M10.05M7.06M5.61M2.32M4.56M-4.14M-2.00M-3.71M6.90M6.53M3.90M6.35M
Change in Account PayablesChange Payables
0.29M3.86M-4.01M2.40M-1.92M0.26M1.03M2.65M2.87M0.42M-2.04M3.82M-0.04M-3.14M0.78M-1.19M2.46M-2.06M1.13M1.60M
Change in Accured ExpensesChange Accured Exp.
0.37M2.52M-0.00M-0.24M0.23M3.44M3.45M0.74M5.06M4.99M-0.05M0.68M4.98M2.32M-4.64M2.23M13.14M6.97M-3.10M-2.23M
Other Working Capital ChangesOther WC Changes
-0.15M-0.07M-0.68M0.11M-0.61M0.73M-0.43M0.33M-0.52M1.74M-0.40M0.04M0.18M
Investing Activities
Capital ExpendituresCapex
0.07M3.18M1.95M4.26M2.93M2.76M0.93M1.38M107.72M41.82M44.17M23.76M48.20M13.61M27.04M9.07M7.62M15.51M36.66M7.09M
Change in Acquisitions & DivestmentsChange Acquisitions
27.50M18.50M14.50M33.75M28.67M
Cash from Investing ActivitiesCash from Investing
6.20M9.99M10.51M22.02M24.75M-2.76M-0.93M-1.38M-149.83M-41.82M-44.17M-23.76M-47.76M-13.61M-27.04M-9.07M-7.62M-15.51M-36.66M-7.09M
Financing Activities
Other financing activitiesOther financing
0.34M0.04M0.20M0.24M1.44M2.79M3.57M0.70M0.95M0.92M2.55M10.64M6.44M1.19M1.74M7.09M1.82M3.10M2.21M1.01M
Cash from Financing ActivitiesCash from Financing
0.55M0.04M0.41M0.24M164.22M3.06M3.96M394.01M1.52M0.92M3.19M10.64M7.86M1.19M3.03M7.09M3.64M3.10M3.76M0.97M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
1.33M0.88M1.20M0.33M0.64M0.30M0.38M0.29M0.35M0.04M
Additional items
Exchange Rate EffectFX Effect
-0.22M-0.30M-0.20M-0.67M-0.61M0.45M0.07M0.01M-0.18M0.29M-0.17M-0.06M0.39M-0.69M0.36M0.81M0.01M0.09M-0.33M-0.25M
Change in Cash
-2.82M3.08M-7.68M12.49M174.08M-3.28M-5.56M386.83M-155.35M-32.30M-44.59M12.53M-32.66M6.56M-26.51M90.43M65.60M22.19M-8.69M10.94M
Free Cash FlowFCF
-9.42M-9.82M-20.36M-13.35M-17.21M-6.80M-9.59M-7.18M-114.59M-33.51M-47.61M1.96M-41.35M6.06M-29.89M82.53M61.95M19.00M-12.12M10.22M
Net Cash FlowNCF
-2.60M3.39M-7.49M13.16M174.69M-3.73M-5.63M386.83M-155.17M-32.59M-44.42M12.60M-33.04M7.24M-26.86M89.62M65.59M22.10M-8.36M11.19M